Advancing Cancer Research with NGS: Custom Panels, Liquid Biopsy & Methylation скачать в хорошем качестве

Advancing Cancer Research with NGS: Custom Panels, Liquid Biopsy & Methylation

Covered in this Webinar: Twist's wide range of Next-Generation Sequencing (NGS) products for cancer research, including customizable panels. The foundation of Twist's offerings is a proprietary silicon wafer platform for DNA synthesis, which provides up to 10,000 times more throughput than traditional methods. Twist's solutions, which include target enrichment and specialized library preparation kits (e.g., cfDNA, methylation), span the full oncology journey, covering screening, profiling, and minimal residual disease (MRD) testing. In this webinar, James Flynn, Staff Product Manager at Twist Bioscience, introduces the company’s comprehensive solutions for cancer research. The presentation demonstrates how Twist’s tools are applied across the entire continuum of cancer research, from screening using whole exome sequencing (Exome 2.0) and RNA Exome panels to early detection and profiling via liquid biopsy (cfDNA) and methylation solutions. Highlighted case studies include St. Jude's custom pan-cancer panel for childhood cancers and IntegraGen's development of a highly sensitive MRD test.